APA (7th ed.) Citation

Yap, T. A., LoRusso, P., Miller, R. E., Kristeleit, R., Paulovich, A. G., McMorn, S., . . . Plummer, R. (2025). The DNA-PK inhibitor AZD7648 alone or combined with pegylated liposomal doxorubicin in patients with advanced cancer. British Journal of Cancer, 1. https://doi.org/10.1038/s41416-025-03053-x

Chicago Style (17th ed.) Citation

Yap, Timothy A., et al. "The DNA-PK Inhibitor AZD7648 Alone or Combined with Pegylated Liposomal Doxorubicin in Patients with Advanced Cancer." British Journal of Cancer 2025: 1. https://doi.org/10.1038/s41416-025-03053-x.

MLA (9th ed.) Citation

Yap, Timothy A., et al. "The DNA-PK Inhibitor AZD7648 Alone or Combined with Pegylated Liposomal Doxorubicin in Patients with Advanced Cancer." British Journal of Cancer, 2025, p. 1, https://doi.org/10.1038/s41416-025-03053-x.